Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 7,266,080 $ 8,186,194
Investments 0 4,933,550
Other current assets 66,433 45,982
Total current assets 7,332,513 13,165,726
Operating lease right-of-use asset 12,646 61,228
Total assets 7,345,159 13,226,954
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 1,757,393 3,128,894
Total current liabilities 1,757,393 3,128,894
Operating lease liability - non-current 0 8,408
Total liabilities 1,757,393 3,137,302
Commitments and contingencies (Note 9)
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 14,904,497 and 12,946,573 shares issued and outstanding as of December 31, 2023, and December 31, 2022, respectively 14,905 12,947
Additional paid-in capital 65,793,210 61,871,784
Accumulated other comprehensive income (loss) (14,132) 8,942
Accumulated deficit (60,206,217) (51,804,021)
Total stockholders’ equity 5,587,766 10,089,652
Total liabilities and stockholders’ equity $ 7,345,159 $ 13,226,954